cancer

Astellas pumps $90m into Sutro immuno-oncology alliance
Pharmaforum
Tue, 06/28/22 - 10:35 am
Astellas
Sutro BioPharma
antibody-drug conjugate
cancer
immuno-oncology
Ipsen beefs up in oncology, buying US biopharma Epizyme
Pharmaforum
Mon, 06/27/22 - 10:52 am
Ipsen
M&A
Epizye
Tazverik
cancer
oncology
Illumina Launches Research Test Codeveloped with Merck to Unlock Deeper Insights into the Tumor Genome
BioSpace
Wed, 06/22/22 - 10:26 am
Medtech
diagnostics
Illumina
Myriad Genetics
TruSight Oncology 500
cancer
Merck
Decentralized trials gaining ground in oncology, says report
Pharmaforum
Fri, 06/17/22 - 09:52 am
clinical trials
oncology
cancer
decentralized clinical trials
Exelixis taps into cancer antibody discoverer out of Sweden
Endpoints
Thu, 06/16/22 - 10:28 am
Exelixis
Bioinvent
cancer
Sweden
immuno-oncology
Boehringer Ingelheim Signs Option to Acquire Immunology Partner, Trutino Biosciences
BioSpace
Wed, 06/15/22 - 10:56 am
Boehringer Ingelheim
Trutino Biosciences
M&A
cancer
Olema Oncology, Aurigene partner to develop new therapies for cancer
Pharmaceutical Business Review
Fri, 06/10/22 - 10:47 am
Olema Oncology
Aurigene
drug development
cancer
CDC awards $215 mln as part of Cancer Moonshot initiative revival
Reuters
Fri, 06/10/22 - 10:36 am
CDC
cancer
oncology
cancer moonshot
Boehringer Ingelheim inks deal for targeted cancer antibodies from Singapore research org
Endpoints
Fri, 06/3/22 - 10:54 am
Boehringer Ingelheim
oncology
cancer
Singapore
R&D
Roche pays Repare $125M to join Big Pharma peers in cancer race
Fierce Biotech
Thu, 06/2/22 - 10:36 am
Roche
cancer
ovarian cancer
Repare Therapeutics
FDA withdraws cancer drug approval after finding possible higher death rates
RAPS.org
Wed, 06/1/22 - 07:39 pm
TG Therapeutics
clinical trials
Ukoniq
cancer
Sapience raises funding to advance cancer therapy programs
Pharmaceutical Business Review
Wed, 06/1/22 - 09:54 am
Sapience Therapeutics
funding
peptide therapeutics
cancer
CureVac increases focus on cancer vaccine development
Biopharma Reporter
Mon, 05/30/22 - 10:17 am
CureVac
myNEO
vaccines
cancer
MRNA
Bristol's Abecma, Amgen's Lumakras headline record-setting oncology launch class as costs continue to balloon: IQVIA
Fierce Pharma
Thu, 05/26/22 - 10:53 pm
oncology
cancer
IQVIA
Bristol Myers Squibb
Abecma
Amgen
Lumakras
3 cancer drug studies to watch at next month’s ASCO meeting
BioPharma Dive
Thu, 05/26/22 - 10:47 pm
ASCO 2022
AstraZeneca
Enhertu
Gilead Sciences
Trodelvy
Roche
tiragolumab
cancer
Merck study results signal blood cancer potential for new type of immunotherapy
BioPharma Dive
Thu, 05/26/22 - 10:40 pm
Merck
Bristol Myers Squibb
cancer
cancer immunotherapy
favezelimab
Hodgkin's lymphoma
Illumina Obtains CDx Pan-Cancer Indication for TruSight Test
Medical Devices and Diagnostics Industry
Wed, 05/25/22 - 10:38 am
Illumina
Medtech
diagnostics
TruSight Oncology
cancer
companion diagnostics
Inceptor Bio generates $37m in funding round as it advances CAR-T platform into the clinic
Biopharma Reporter
Wed, 05/25/22 - 10:13 am
Inceptor Bio
CAR-T
funding
cell therapy
cancer
Inceptor Bio Announces $37 Million Series A Financing to Develop Cell Therapies for Difficult-to-Treat Cancers
BioSpace
Thu, 05/19/22 - 10:52 am
Inceptor Bio
cancer
cell therapy
funding
Laekna Therapeutics Raises $61 Million in Series D financing
BioSpace
Wed, 05/18/22 - 10:28 am
Laekna Therapeutics
funding
liver disease
cancer

Pages